The reported statements, read against the company's own industry.
Financials view
Market Capitalization
39.69BHKD
5.06B · vs all stocks (USD)
Updated Aug 19, 2026
Revenue (TTM)
201.83BCNY
25.73B · vs all stocks (USD)
Updated Aug 19, 2026
Profit Margin
-13.49%
vs Conglomerates peers
Updated Aug 19, 2026
Beta
0.4690x
vs all stocks
Updated Aug 19, 2026
52-Week Change
-7.13%
vs all stocks
Updated Aug 19, 2026
Market Capitalization
39.69BHKD
5.06B · vs all stocks (USD)
Updated Aug 19, 2026
Enterprise Value
301.14BHKD
38.39B · vs all stocks (USD)
Updated Aug 19, 2026
Forward P/E
11.32x
vs Conglomerates peers
Updated Aug 19, 2026
Price to Sales (TTM)
0.2371x
vs Conglomerates peers
Provider-reported. Market Capitalization ÷ Revenue (TTM) on this page gives 0.2×.Updated Aug 19, 2026
Price to Book (MRQ)
0.3765x
vs Conglomerates peers
Updated Aug 19, 2026
Enterprise to Revenue
1.49x
vs Conglomerates peers
Updated Aug 19, 2026
Enterprise to EBITDA
-16.68x
vs Conglomerates peers
Updated Aug 19, 2026
Profit Margin
-13.49%
vs Conglomerates peers
Updated Aug 19, 2026
Return on Assets (TTM)
-1.97%
vs Conglomerates peers
Updated Aug 19, 2026
Return on Equity (TTM)
-12.42%
vs Conglomerates peers
Updated Aug 19, 2026
Revenue (TTM)
201.83BCNY
25.73B · vs all stocks (USD)
Updated Aug 19, 2026
Revenue per Share (TTM)
21.35CNYUpdated Aug 19, 2026
Quarterly Revenue Growth
-8.70%
vs Conglomerates peers
Updated Aug 19, 2026
Gross Profit (TTM)
55.67BCNY
7.10B · vs all stocks (USD)
Updated Aug 19, 2026
EBITDA (TTM)
-18.05BCNY
-2.30B · vs all stocks (USD)
Updated Aug 19, 2026
Net Income (TTM)
-27.23BCNY
-3.47B · vs all stocks (USD)
Updated Aug 19, 2026
Operating Cash Flow (TTM)
30.94BCNY
3.94B · vs all stocks (USD)
Updated Aug 19, 2026
Levered Free Cash Flow (TTM)
18.20BCNY
2.32B · vs all stocks (USD)
Updated Aug 19, 2026
5-Year Average Dividend Yield
1.82%
vs all stocks
Updated Aug 19, 2026
Payout Ratio
39.30%
vs Conglomerates peers
Updated Aug 19, 2026
Minority Interest (Equity)
74.47BCNYFY2025 · Dec 31, 2025
Revenue
173.43BCNYFY2025 · Dec 31, 2025
Cost of Goods Sold
125.59BCNYFY2025 · Dec 31, 2025
Gross Profit
47.84BCNYFY2025 · Dec 31, 2025
Operating Income
4.29BCNY
636.73M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
-21.58BCNYFY2025 · Dec 31, 2025
Income Tax Expense
1.13BCNYFY2025 · Dec 31, 2025
Net Income
-22.71BCNYFY2025 · Dec 31, 2025
EBIT
-9.21BCNYFY2025 · Dec 31, 2025
EBITDA (Income Statement)
-425.83MCNYFY2025 · Dec 31, 2025
Selling, General & Administrative
44.35BCNYFY2025 · Dec 31, 2025
Other Operating Expenses
-107.05MCNYFY2025 · Dec 31, 2025
Non-operating Interest Income
4.51BCNYFY2025 · Dec 31, 2025
Non-operating Interest Expense
12.37BCNYFY2025 · Dec 31, 2025
EPS (Basic)
-2.88CNYFY2025 · Dec 31, 2025
EPS (Diluted)
-2.88CNYFY2025 · Dec 31, 2025
Basic Shares Outstanding
8.12BSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
8.12BSharesFY2025 · Dec 31, 2025
Minority Interests (P&L)
-685.07MCNYFY2025 · Dec 31, 2025
Preferred Stock Dividends
664.00KCNYFY2025 · Dec 31, 2025
Operating Cash Flow
4.67BCNYFY2025 · Dec 31, 2025
Free Cash Flow
-2.59BCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
42.19BCNYFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
-21.58BCNYFY2025 · Dec 31, 2025
Stock-based Compensation
425.25MCNYFY2025 · Dec 31, 2025
Other Non-cash Items
11.23BCNYFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
1.56BCNYFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
13.04BCNYFY2025 · Dec 31, 2025
Capital Expenditures
-7.26BCNYFY2025 · Dec 31, 2025
Net Intangibles (CF)
-2.22BCNYFY2025 · Dec 31, 2025
Net Acquisitions
-52.89BCNYFY2025 · Dec 31, 2025
Purchase of Investments
-148.74BCNYFY2025 · Dec 31, 2025
Sale of Investments
139.39BCNYFY2025 · Dec 31, 2025
Other Investing Activity
2.15BCNYFY2025 · Dec 31, 2025
Net Investing Cash Flow
-67.35BCNYFY2025 · Dec 31, 2025
Long-term Debt Issuance
162.12BCNYFY2025 · Dec 31, 2025
Long-term Debt Payments
-158.36BCNYFY2025 · Dec 31, 2025
Common Stock Repurchase
-115.93MCNYFY2025 · Dec 31, 2025
Common Dividends Paid
-203.18MCNYFY2025 · Dec 31, 2025
Other Financing Charges
-461.86MCNYFY2025 · Dec 31, 2025
Net Financing Cash Flow
2.98BCNYFY2025 · Dec 31, 2025
Shares Outstanding
8.14BSharesUpdated Aug 19, 2026
Float Shares
2.17BSharesUpdated Aug 19, 2026
% Held by Insiders
73.37%
vs all stocks
Updated Aug 19, 2026
% Held by Institutions
2.37%
vs all stocks
Updated Aug 19, 2026
Total Cash (MRQ)
123.76BCNY
15.78B · vs all stocks (USD)
Updated Aug 19, 2026
Total Cash per Share (MRQ)
13.09CNYUpdated Aug 19, 2026
Total Debt (MRQ)
291.81BCNY
37.20B · vs all stocks (USD)
Updated Aug 19, 2026
Total Debt to Equity (MRQ)
1.49x
vs Conglomerates peers
Updated Aug 19, 2026
Current Ratio (MRQ)
1.12x
vs Conglomerates peers
Updated Aug 19, 2026
Book Value per Share (MRQ)
13.44CNYUpdated Aug 19, 2026
Total Assets
716.23BCNY
106.22B · vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
234.97BCNYFY2025 · Dec 31, 2025
Total Liabilities
547.93BCNYFY2025 · Dec 31, 2025
Total Non-current Assets
481.26BCNYFY2025 · Dec 31, 2025
Total Non-current Liabilities
297.43BCNYFY2025 · Dec 31, 2025
Total Current Liabilities
250.50BCNYFY2025 · Dec 31, 2025
Cash
42.19BCNYFY2025 · Dec 31, 2025
Cash Equivalents
3.27BCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents
45.46BCNYFY2025 · Dec 31, 2025
Other Short-term Investments
51.97BCNYFY2025 · Dec 31, 2025
Accounts Receivable
13.14BCNYFY2025 · Dec 31, 2025
Inventory
57.44BCNYFY2025 · Dec 31, 2025
Accounts Payable
20.05BCNYFY2025 · Dec 31, 2025
Short-term Debt
108.68BCNYFY2025 · Dec 31, 2025
Other Current Liabilities
1.57BCNYFY2025 · Dec 31, 2025
Long-term Debt
142.00BCNYFY2025 · Dec 31, 2025
Other Non-current Liabilities
-2.27BCNYFY2025 · Dec 31, 2025
Common Stock (Book)
37.44BCNYFY2025 · Dec 31, 2025
Retained Earnings
40.06BCNYFY2025 · Dec 31, 2025
Total Shareholders' Equity
168.30BCNY
24.96B · vs all stocks (USD)
FY2025 · Dec 31, 2025
Treasury Stock
173.61MCNYFY2025 · Dec 31, 2025
52-Week Low
3.42HKDUpdated Aug 19, 2026
52-Week High
5.79HKDUpdated Aug 19, 2026
52-Week Change
-7.13%
vs all stocks
Updated Aug 19, 2026
Beta
0.4690x
vs all stocks
Updated Aug 19, 2026
50-Day MA
4.25HKDUpdated Aug 19, 2026
200-Day MA
4.25HKDUpdated Aug 19, 2026
Avg 10-Day Volume
13.27MSharesUpdated Aug 19, 2026
Avg 30-Day Volume
11.42MSharesUpdated Aug 19, 2026
Diluted EPS (TTM)
-3.35CNYUpdated Aug 19, 2026
2 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Debt is a large share of its assets, and large against its cash flow.
Reads
Elevated Leverage on Three Denominators
Debt sits high against its equity, its assets, and its cash flow.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 0.29: distress zoneCritical
Altman Z-Score: 0.29
High earnings qualityNotable
Earnings Quality Score: 0.82
Supply Chain
Upstream position: supplies 8 industries, depends on 0Notable
Outgoing: 8.00Incoming: 0.00
Scale
Revenue is $25.73B, higher than 95% of all stocks globallySignificant